Search Results - "Ljunggren, Osten"

Refine Results
  1. 1
  2. 2

    Complications and adverse effects related to surgical and medical treatment in patients with inflammatory bowel disease in a prospectively recruited population-based cohort by Rönnblom, Anders, Ljunggren, Östen, Karlbom, Urban

    Published in Scandinavian journal of gastroenterology (02-11-2021)
    “…Medical adverse effects and surgical complications have been reported during treatment of patients with inflammatory bowel diseases (IBDs). There is however a…”
    Get full text
    Journal Article
  3. 3

    Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells by Krajisnik, Tijana, Björklund, Peyman, Marsell, Richard, Ljunggren, Östen, Åkerström, Göran, Jonsson, Kenneth B, Westin, Gunnar, Larsson, Tobias E

    Published in Journal of endocrinology (01-10-2007)
    “…Fibroblast growth factor-23 (FGF23) is a circulating factor that decreases serum levels of inorganic phosphate (Pi) as well as 1,25-dihydroxyvitamin D3. Recent…”
    Get full text
    Journal Article
  4. 4

    Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men by Tivesten, Åsa, Vandenput, Liesbeth, Labrie, Fernand, Karlsson, Magnus K., Ljunggren, Östen, Mellström, Dan, Ohlsson, Claes

    “…Context: Age-related reduction of serum testosterone may contribute to the signs and symptoms of aging, but previous studies report conflicting evidence about…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men by Kindblom, Jenny M, Ohlsson, Claes, Ljunggren, Östen, Karlsson, Magnus K, Tivesten, Åsa, Smith, Ulf, Mellström, Dan

    Published in Journal of bone and mineral research (01-05-2009)
    “…The osteoblast‐derived protein osteocalcin has recently been shown to affect adiposity and glucose homeostasis in mice, suggesting that the skeleton influences…”
    Get full text
    Journal Article
  7. 7

    THERAPY OF ENDOCRINE DISEASE: Treatment of osteogenesis imperfecta in adults by Lindahl, Katarina, Langdahl, Bente, Ljunggren, Östen, Kindmark, Andreas

    Published in European journal of endocrinology (01-08-2014)
    “…BackgroundOsteogenesis imperfecta (OI) is a heterogeneous rare connective tissue disorder commonly caused by mutations in the collagen type I genes…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta by Lindahl, Katarina, Åström, Eva, Rubin, Carl-Johan, Grigelioniene, Giedre, Malmgren, Barbro, Ljunggren, Östen, Kindmark, Andreas

    Published in European journal of human genetics : EJHG (01-08-2015)
    “…Osteogenesis imperfecta (OI) is a rare hereditary bone fragility disorder, caused by collagen I mutations in 90% of cases. There are no comprehensive…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Serum Glycine Levels Are Associated With Cortical Bone Properties and Fracture Risk in Men by Eriksson, Anna L, Friedrich, Nele, Karlsson, Magnus K, Ljunggren, Östen, Lorentzon, Mattias, Nethander, Maria, Wallaschofski, Henri, Mellström, Dan, Ohlsson, Claes

    “…In a recent study a pattern of 27 metabolites, including serum glycine, associated with bone mineral density (BMD). To investigate associations for serum and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effects of glucocorticoids on vitamin D3-metabolizing 24-hydroxylase (CYP24A1) in Saos-2 cells and primary human osteoblasts by Zayny, Ahmad, Almokhtar, Mokhtar, Wikvall, Kjell, Ljunggren, Östen, Ubhayasekera, Kumari, Bergquist, Jonas, Kibar, Pinar, Norlin, Maria

    Published in Molecular and cellular endocrinology (01-10-2019)
    “…Vitamin D is essential for bone function and deficiency in active vitamin D hormone can lead to bone disorders. Long-term treatment with glucocorticoids…”
    Get full text
    Journal Article
  16. 16

    The association between peripheral arterial disease and risk for hip fractures in elderly men is not explained by low hip bone mineral density. Results from the MrOS Sweden study by Bokrantz, Tove, Manhem, Karin, Lorentzon, Mattias, Karlsson, Magnus, Ljunggren, Östen, Ohlsson, Claes, Mellström, Dan

    Published in Osteoporosis international (2022)
    “…Summary In this prospective study in Swedish elderly men, PAD based on an ABI < 0.9 was associated with an increased risk of hip fracture, independent of age…”
    Get full text
    Journal Article
  17. 17

    High‐Sensitivity CRP Is an Independent Risk Factor for All Fractures and Vertebral Fractures in Elderly Men: The MrOS Sweden Study by Eriksson, Anna L, Movérare‐Skrtic, Sofia, Ljunggren, Östen, Karlsson, Magnus, Mellström, Dan, Ohlsson, Claes

    Published in Journal of bone and mineral research (01-02-2014)
    “…ABSTRACT Epidemiological studies have shown low‐grade inflammation measured by high‐sensitivity C‐reactive protein (hs‐CRP) to be associated with fracture risk…”
    Get full text
    Journal Article
  18. 18

    Low Serum Levels of Dehydroepiandrosterone Sulfate Predict All-Cause and Cardiovascular Mortality in Elderly Swedish Men by Ohlsson, Claes, Labrie, Fernand, Barrett-Connor, Elizabeth, Karlsson, Magnus K., Ljunggren, Östen, Vandenput, Liesbeth, Mellström, Dan, Tivesten, Åsa

    “…Context: The age-related decline in dehydroepiandrosterone (DHEA) levels is thought to be of importance for general and vascular aging. However, data on the…”
    Get full text
    Journal Article
  19. 19

    Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy by Khamisi, Selwan, Lundqvist, Martin, Engström, Britt Edén, Larsson, Anders, Karlsson, F Anders, Ljunggren, Östen

    “…TSH-receptor antibodies (TRAb) targeting the TSH receptor (TSH-R) induce hyperthyroidism in Graves´ disease (GD). Graves´ orbitopathy (GO) is influenced by…”
    Get more information
    Journal Article
  20. 20